Mastocytosis
Overview of systemic and cutaneous mastocytosis.
Reviewed by Dr Kola Tytler MBBS CertHE MBA MRCGP (General Practitioner)
Last reviewed: 21 October 2025
Clinical Guidelines
Standards and standardization in mastocytosis: Consensus Statements on Diagnostics, Treatment Recommendations and Response Criteria (Eur J Clin Invest, 2007)
National
Standards and standardization in mastocytosis: Consensus Statements on Diagnostics, Treatment Recommendations and Response Criteria (Eur J Clin Invest. 2007)National
Systemic Mastocytosis, NCCN Clinical Practice Guidelines in Oncology (Version 2025)National
Diagnosis and treatment of Hymenoptera venom allergy: S2k Guideline of the German Society for Allergology and Clinical Immunology (DGAKI)Local
Harmonization of Diagnostic Criteria in Mastocytosis for Use in Clinical Practice: WHO vs ICC vs AIM/ECNMLocal
Standards and standardization in mastocytosis: Consensus Statements on Diagnostics, Treatment Recommendations and Response CriteriaLocal
Systemic mastocytosis version 2.2022, NCCN Clinical Practice Guidelines in OncologyLocal
Systemic Mastocytosis, Version 2.2019, NCCN Clinical Practice Guidelines in OncologyLocal
Systemic Mastocytosis. Version: 1.2025. NCCN Clinical Practice Guidelines in OncologyLocal
Tryptase Test System as an Aid in the Diagnosis of Systemic Mastocytosis - Class II Special Controls GuidelineLocal